The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(5-((benzyloxy)methyl)-3-((1-benzylpiperidin-4-yl)methyl)-2-oxotetrahydropyrimidin-1(2H)-yl)benzimidamide ID: ALA3780036
Chembl Id: CHEMBL3780036
PubChem CID: 123424620
Max Phase: Preclinical
Molecular Formula: C32H39N5O2
Molecular Weight: 525.70
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: N=C(N)c1cccc(N2CC(COCc3ccccc3)CN(CC3CCN(Cc4ccccc4)CC3)C2=O)c1
Standard InChI: InChI=1S/C32H39N5O2/c33-31(34)29-12-7-13-30(18-29)37-22-28(24-39-23-27-10-5-2-6-11-27)21-36(32(37)38)20-26-14-16-35(17-15-26)19-25-8-3-1-4-9-25/h1-13,18,26,28H,14-17,19-24H2,(H3,33,34)
Standard InChI Key: SNXRYLUCKVDDCE-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 525.70Molecular Weight (Monoisotopic): 525.3104AlogP: 4.96#Rotatable Bonds: 10Polar Surface Area: 85.89Molecular Species: BASEHBA: 4HBD: 2#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 11.17CX LogP: 3.88CX LogD: -0.03Aromatic Rings: 3Heavy Atoms: 39QED Weighted: 0.29Np Likeness Score: -1.07
References 1. Venukadasula PK, Owusu BY, Bansal N, Ross LJ, Hobrath JV, Bao D, Truss JW, Stackhouse M, Messick TE, Klampfer L, Galemmo RA.. (2016) Design and Synthesis of Nonpeptide Inhibitors of Hepatocyte Growth Factor Activation., 7 (2): [PMID:26985294 ] [10.1021/acsmedchemlett.5b00357 ]